BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2369138)

  • 1. [Antitumor effect of a novel antitumor compound, NC-190, in the double grafted tumor system].
    Ebina T; Shishido K; Murata K
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1345-50. PubMed ID: 2369138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumor effect of Cepharanthin in the double grafted tumor system].
    Ebina T; Ishikawa K; Murata K
    Gan To Kagaku Ryoho; 1990 Jun; 17(6):1165-71. PubMed ID: 2350192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimetastatic effect of biological response modifiers in the "double grafted tumor system".
    Ebina T; Kohya H; Yamaguchi T; Ishida N
    Jpn J Cancer Res; 1986 Oct; 77(10):1034-42. PubMed ID: 3096919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitumor Effector mechanism of plant alkaloid preparation, cepharanthin, by intratumoral administration].
    Ebina T; Murata K
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1812-6. PubMed ID: 1877822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor effect of PSK (2): effector mechanism of the antimetastatic effect in the "double grafted tumor system"].
    Ebina T; Kohya H
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1847-53. PubMed ID: 3592718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antitumor effect of OK-432 (3)--mechanisms of tumor growth inhibition by OK-432 induced activated macrophages].
    Nanjo M; Saito M; Aonuma E; Fujimura H; Nakamura T; Aso H; Yoshie O; Ebina T; Ishida N
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):887-93. PubMed ID: 3885861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of levamisole on methylcholanthrene-induced tumor. I. Its antitumor effect and immunological mechanism].
    Gomi K; Morimoto M; Nomoto K
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1262-8. PubMed ID: 7184454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effector mechanism at a distant site in the double grafted tumor system of PSK, a protein-bound polysaccharide preparation.
    Ebina T; Kohya H
    Jpn J Cancer Res; 1988 Aug; 79(8):957-64. PubMed ID: 3141330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of interleukin-1 beta in the double grafted tumor system.
    Ebina T; Ishikawa K
    Jpn J Cancer Res; 1989 Jun; 80(6):570-6. PubMed ID: 2503477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432].
    Saito M; Aonuma E; Noda T; Nakadate I; Nanjo M; Ebina T; Ishida N
    Gan To Kagaku Ryoho; 1983 May; 10(5):1363-71. PubMed ID: 6870302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effector mechanism of interleukin-1 beta at a distant site in the double grafted tumor system.
    Ebina T; Murata K
    Jpn J Cancer Res; 1991 Nov; 82(11):1292-8. PubMed ID: 1752785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots.
    Suzuki F; Schmitt DA; Utsunomiya T; Pollard RB
    In Vivo; 1992; 6(6):589-96. PubMed ID: 1296807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curative intravenous adoptive immunotherapy of Meth A murine sarcoma. A histologic and immunohistochemical assessment.
    Reichert CM; Rosenstein M; Von Glatz J; Hsu SM; Rosenberg SA
    Lab Invest; 1985 Mar; 52(3):304-13. PubMed ID: 3974201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.
    Chou T; Shu S
    J Immunol; 1987 Sep; 139(6):2103-9. PubMed ID: 2957448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential requirement of I-A region-identical host bone marrow or bone marrow-derived cells for tumor neutralization by primed L3T4+ T cells.
    Ozawa H; Iwaguchi T; Kataoka T
    J Immunol; 1987 Dec; 139(11):3896-901. PubMed ID: 2960743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
    J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regional adoptive immunotherapy using activated lymphocytes].
    Ebina T; Isono N; Murata K; Yokoyama J; Mikuni J; Ohuchi K
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1549-52. PubMed ID: 8854802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of experimental pulmonary metastasis and inhibition of subcutaneously transplanted tumor growth following cryosurgery.
    Shibata T; Yamashita T; Suzuki K; Takeichi N; Micallef M; Hosokawa M; Kobayashi H; Murata M; Arisue M
    Anticancer Res; 1998; 18(6A):4443-8. PubMed ID: 9891507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.